1. Home
  2. CYTK vs PRI Comparison

CYTK vs PRI Comparison

Compare CYTK & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$61.68

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Primerica Inc.

PRI

Primerica Inc.

N/A

Current Price

$252.03

Market Cap

8.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
PRI
Founded
1997
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.0B
IPO Year
2004
2009

Fundamental Metrics

Financial Performance
Metric
CYTK
PRI
Price
$61.68
$252.03
Analyst Decision
Strong Buy
Hold
Analyst Count
18
4
Target Price
$87.56
$300.25
AVG Volume (30 Days)
1.7M
217.4K
Earning Date
05-25-2026
05-13-2026
Dividend Yield
N/A
1.89%
EPS Growth
N/A
67.10
EPS
N/A
22.91
Revenue
$13,368,000.00
$3,291,713,000.00
Revenue This Year
$9.79
$4.69
Revenue Next Year
$302.66
$5.08
P/E Ratio
N/A
$11.11
Revenue Growth
N/A
6.56
52 Week Low
$29.31
$230.09
52 Week High
$70.98
$296.00

Technical Indicators

Market Signals
Indicator
CYTK
PRI
Relative Strength Index (RSI) 44.80 41.78
Support Level $59.25 $230.09
Resistance Level $65.93 $269.94
Average True Range (ATR) 2.44 6.56
MACD -0.31 -0.52
Stochastic Oscillator 21.01 12.25

Price Performance

Historical Comparison
CYTK
PRI

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

Share on Social Networks: